AU9297798A - Substituted 1,2,4-triazoles useful for inhibiting cholesteryl ester transfer protein activity - Google Patents
Substituted 1,2,4-triazoles useful for inhibiting cholesteryl ester transfer protein activityInfo
- Publication number
- AU9297798A AU9297798A AU92977/98A AU9297798A AU9297798A AU 9297798 A AU9297798 A AU 9297798A AU 92977/98 A AU92977/98 A AU 92977/98A AU 9297798 A AU9297798 A AU 9297798A AU 9297798 A AU9297798 A AU 9297798A
- Authority
- AU
- Australia
- Prior art keywords
- substituted
- protein activity
- transfer protein
- cholesteryl ester
- ester transfer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5901897P | 1997-09-16 | 1997-09-16 | |
| US60059018 | 1997-09-16 | ||
| PCT/US1998/018170 WO1999014204A1 (en) | 1997-09-16 | 1998-09-14 | Substituted 1,2,4-triazoles useful for inhibiting cholesteryl ester transfer protein activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU9297798A true AU9297798A (en) | 1999-04-05 |
Family
ID=22020294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU92977/98A Abandoned AU9297798A (en) | 1997-09-16 | 1998-09-14 | Substituted 1,2,4-triazoles useful for inhibiting cholesteryl ester transfer protein activity |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU9297798A (en) |
| WO (1) | WO1999014204A1 (en) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2894445B2 (en) | 1997-02-12 | 1999-05-24 | 日本たばこ産業株式会社 | Compounds effective as CETP activity inhibitors |
| AU2157500A (en) * | 1998-12-23 | 2000-07-31 | G.D. Searle Llc | Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications |
| JP2002533410A (en) * | 1998-12-23 | 2002-10-08 | ジー．ディー．サール エルエルシー | Combination of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular applications |
| ATE242007T1 (en) * | 1998-12-23 | 2003-06-15 | Searle Llc | COMBINATIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND NICOTINIC ACID DERIVATIVES FOR CARDIOVASCULAR INDICATIONS |
| EP1140188B1 (en) * | 1998-12-23 | 2003-05-28 | G.D. Searle LLC. | Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications |
| US20010018446A1 (en) | 1999-09-23 | 2001-08-30 | G.D. Searle & Co. | Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| US6586433B2 (en) | 1999-09-23 | 2003-07-01 | Pharmacia Corporation | Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| US6723752B2 (en) | 1999-09-23 | 2004-04-20 | Pharmacia Corporation | (R)-chiral halogenated substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| US6677382B1 (en) | 1999-09-23 | 2004-01-13 | Pharmacia Corporation | Substituted N,N-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| US7115279B2 (en) | 2000-08-03 | 2006-10-03 | Curatolo William J | Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| CZ20033341A3 (en) * | 2001-06-21 | 2004-10-13 | Pfizeráproductsáinc | Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| EP1269994A3 (en) | 2001-06-22 | 2003-02-12 | Pfizer Products Inc. | Pharmaceutical compositions comprising drug and concentration-enhancing polymers |
| EP1404302B1 (en) | 2001-06-22 | 2010-11-03 | Pfizer Products Inc. | Pharmaceutical compositions comprising adsorbates of amorphous drug |
| JP2004534812A (en) * | 2001-06-22 | 2004-11-18 | ファイザー・プロダクツ・インク | Pharmaceutical composition of dispersion of drug and neutral polymer |
| ES2305434T3 (en) | 2002-02-01 | 2008-11-01 | Pfizer Products Inc. | FRAMACEUTICAL COMPOSITIONS OF AMORPHIC DISPERSIONS OF PHARMACS AND MATERIALS FORMING LIPOFIL MICROPHASES. |
| AR038375A1 (en) | 2002-02-01 | 2005-01-12 | Pfizer Prod Inc | PHARMACEUTICAL COMPOSITIONS OF INHIBITORS OF THE PROTEIN OF TRANSFER OF ESTERES DE COLESTERILO |
| WO2003066050A1 (en) * | 2002-02-07 | 2003-08-14 | The Curators Of The University Of Missouri | Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds |
| AR039385A1 (en) | 2002-04-19 | 2005-02-16 | Astrazeneca Ab | THIOXANTINE DERIVATIVES AS INHIBITORS OF MIELOPEROXIDASA |
| DE60323536D1 (en) | 2002-12-20 | 2008-10-23 | Pfizer Prod Inc | DOSAGE FORM CONTAINING A CETP INHIBITOR AND AN HMG-COA REDUCTASE HEMMER |
| CA2519432C (en) | 2003-03-17 | 2009-06-09 | Japan Tobacco Inc. | Pharmaceutical compositions comprising cetp inhibitors and a water-insoluble concentration-enhancing additive for the treatment of cardiovascular disease |
| AU2004222436A1 (en) | 2003-03-17 | 2004-09-30 | Japan Tobacco Inc. | Method for increasing the oral bioavailability of S-(2-(((1- (2-ethylbutyl) cyclohexyl)carbonyl) amino) phenyl)-2-methylpropanethioate |
| CL2004001884A1 (en) | 2003-08-04 | 2005-06-03 | Pfizer Prod Inc | DRYING PROCEDURE FOR SPRAYING FOR THE FORMATION OF SOLID DISPERSIONS AMORPHES OF A PHARMACO AND POLYMERS. |
| JP2007501218A (en) | 2003-08-04 | 2007-01-25 | ファイザー・プロダクツ・インク | Pharmaceutical composition of adsorbate of amorphous drug and lipophilic microphase-forming substance |
| KR20070087197A (en) | 2003-09-26 | 2007-08-27 | 니뽄 다바코 산교 가부시키가이샤 | Method of inhibiting remnant lipoprotein production |
| MY140748A (en) | 2004-12-06 | 2010-01-15 | Astrazeneca Ab | Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy |
| EP1844078B1 (en) | 2005-02-03 | 2016-09-28 | Bend Research, Inc | Pharmaceutical compositions with enhanced performance |
| WO2006098394A1 (en) * | 2005-03-14 | 2006-09-21 | Japan Tobacco Inc. | Method for inhibiting lipid absorption and lipid absorption inhibitor |
| JP2009512715A (en) | 2005-10-21 | 2009-03-26 | ノバルティス アクチエンゲゼルシャフト | Combination of renin inhibitor and anti-dyslipidemic agent and / or anti-obesity agent |
| TW200804383A (en) | 2006-06-05 | 2008-01-16 | Astrazeneca Ab | New compounds |
| WO2012027331A1 (en) | 2010-08-27 | 2012-03-01 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
| WO2014199164A1 (en) * | 2013-06-12 | 2014-12-18 | Ampla Pharmaceuticals, Inc. | Diaryl substituted heteroaromatic compounds |
| CN107001697B (en) | 2014-11-24 | 2019-06-28 | 路博润先进材料公司 | Novel coupling uracil compound for chloride polymer resin |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3701784A (en) * | 1968-09-04 | 1972-10-31 | Rohm & Haas | 1,2,4-4h-triazole derivatives |
| FR2546887B1 (en) * | 1983-05-30 | 1985-08-30 | Paris 7 Universite | PROCESS FOR THE PREPARATION OF 2,4-DIHYDRO-TRIAZOL-1,2,4 THIONES-3 DISUBSTITUTED IN POSITIONS 4 AND 5 AND NOVEL COMPOUNDS THAT CAN BE PREPARED BY THIS PROCESS |
-
1998
- 1998-09-14 WO PCT/US1998/018170 patent/WO1999014204A1/en active Application Filing
- 1998-09-14 AU AU92977/98A patent/AU9297798A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999014204A1 (en) | 1999-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU9297798A (en) | Substituted 1,2,4-triazoles useful for inhibiting cholesteryl ester transfer protein activity | |
| AU3285499A (en) | Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity | |
| AU4073997A (en) | 1,4-heterocyclic metallprotease inhibitors | |
| AU5236698A (en) | General access system | |
| AU7181798A (en) | Merchandizing system | |
| AU8497898A (en) | Order pick system | |
| AU1699797A (en) | Tangle-resistant leash | |
| AU6161099A (en) | Substituted n-aliphatic-n-aromatic (tertiary)-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity | |
| AU1559199A (en) | Isothiazolcarboxylic acid derivatives | |
| AU3340797A (en) | Modified oligonucleotides | |
| AU9066598A (en) | Substituted 4-benzoyl-pyrazoles | |
| AU7476598A (en) | 18-substituted-19-nor-vitamin d compounds | |
| AU5208598A (en) | Computer kiosk | |
| AU5345798A (en) | Fructan-polycarboxylic acid | |
| AU6090898A (en) | Substituted 4-benzoyl-pyrazoles | |
| AUPP003297A0 (en) | 4,5-diaryloxazole compounds | |
| AU2638597A (en) | Access control system | |
| AU6900598A (en) | Record system | |
| AU2696897A (en) | Modified oligonucleotides | |
| AU5779598A (en) | Triazole derivatives | |
| AU7212698A (en) | Substituted aryluracils | |
| AU7530198A (en) | Substituted 4-benzoyl-pyrazoles | |
| AU2991397A (en) | Heterocyclic compounds | |
| AUPP029797A0 (en) | Modifications for improved biological response 2 | |
| AUPP029897A0 (en) | Modifications for improved biological response 3 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |